Cramer: Apple Is Th...
Health Care: Health Services
Covidien PLC (COV: NYSE)
$50.67 -1.11 | -2.14%
06/01/12 - 04:01 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 12.60 | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 0.85 | 0.77 | 0.98 |
| Price to Sales (TTM) | 2.06 | 1.97 | 1.42 |
| Price to Book (MRQ) | 2.32 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | -91.87 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | 9.40 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | 28.30 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 1.80 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 21.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 5.20 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 11.00 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | n.a. | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 9.20 | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 9.20 | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.30 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 2.30 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.36 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.41 | 0.34 | 0.96 |
| Interest Coverage (TTM) | 12.30 | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 62.80 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 58.00 | 59.90 | 47.70 |
| EBITD Margin (TTM) | 26.80 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | 25.19 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 19.30 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 15.40 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.17 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 10.30 | 8.70 | 7.00 |
| Return on Assets (TTM) | 9.30 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | 5.90 | 5.20 | 2.50 |
| Return on Investment (TTM) | 13.80 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | 9.10 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 286,877.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | 47,869.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 6.10 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 2.80 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.60 | 0.60 | 0.40 |
Portfolios with COV
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- ProJohn Paulson
- ContributorTop-Yielding Health Service...
- UserGFNN Stockdiagnostics 4
- ProKaren Finerman - Metropolit...
- ProPrivate Capital Management
- ContributorHealth Care Stocks Bought a...
- ContributorJohn Paulson's 10 Best New ...
- Contributor8 Health Care Stocks to Buy
- ProTPG-Axon Capital
Latest COV Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.24.12 | 05:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.08.12 | 04:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.01.12 | 05:05 pm
- Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript 04.27.12 | 01:04 pm
- Covidien Stock To Go Ex-dividend Monday (COV) 03.30.12 | 09:03 am
- 8 Ex-Dividend Stocks With Buy Ratings 03.30.12 | 05:03 am
- Tyco Investors Not Free From Kozlowski 03.29.12 | 09:03 am
- Pfizer Needs to Think About Splitting: Goldman 03.27.12 | 03:03 pm
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
Press Releases for COV
- Endo GIA(TM) Radial Reload With Tri-Staple(TM) Technology (Photo: Business Wire) - Business Wire 05.31.12 | 06:05 pm
- Covidien To Present At Goldman Sachs Conference - Business Wire 05.31.12 | 07:05 am
- Covalon Provides Corporate Update And Second Quarter Fiscal 2012 Financial Results - PR Newswire 05.28.12 | 08:05 am
- Covidien Announces Pricing Of $1.250 Billion Senior Notes Offering - Business Wire 05.22.12 | 04:05 pm
- Covidien Announces Senior Notes Offering And Redemption Of 5.450% Senior Notes Due October 2012 - Business Wire 05.22.12 | 09:05 am
- Covidien Appoints Gregory S. Andrulonis Vice President And Treasurer - Business Wire 05.21.12 | 04:05 pm
- Covalon To Unveil Its SilverCoat⢠Antimicrobial Silicone Foley Catheter At The 2012 American Urological Association Annual Meeting In Atlanta - PR Newswire 05.18.12 | 01:05 pm
- Covidien Completes Acquisition Of SuperDimension, Ltd. - Business Wire 05.15.12 | 04:05 pm
- Covalon Announces Major Milestone: Achieves FDA Approval For IV Clear⢠- A Breakthrough Antimicrobial Silicone Adhesive Film Dressing For Securing Vascular Access Medical Devices - PR Newswire 05.15.12 | 08:05 am
- Covidien, A Leading Global Provider Of Healthcare Products, Will Unveil Its New OneShot™ Renal Denervation System At The EuroPCR Congress In Paris, France, On May 16, 2012. (Photo: Business Wire) - Business Wire 05.08.12 | 07:05 am
Partner Headlines for COV
- COV Launches Endo GIA Radial Reload - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Covidien Prices Senior Notes - Analyst Blog - Zacks 05.25.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom and NOV, COV, ABVT, TNB - GuruFocus 05.17.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom - GuruFocus 05.17.12 | 04:05 pm
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- UPDATE: Deutsche Bank Raises PT to $62 on Covidien; FQ2 Beats Expectations - Benzinga 05.01.12 | 09:05 am
- Covidien to Acquire Oridion Systems - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- Covidien Takes Over superDimension - Analyst Blog - Zacks 04.03.12 | 09:04 am
- Covidien Announces Study Results Demonstrating Benefits of Minimally Invasive Surgery over Traditional Open Procedures - Benzinga 03.12.12 | 04:03 pm
- The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases - Zacks 03.08.12 | 09:03 am
